Ecron Acunova and Newcastle University have signed a Memorandum of Understanding signalling an intention by both parties to explore ways of working closely together in the area of clinical trials.
The Memorandum of Understanding builds on a number of initial discussions, recently under the terms of Confidentiality Agreements, on how the two organisations can work together.
Newcastle University hosts one of the leading medical schools in the UK with a clear focus on translational research and has a very close relationship with a number of excellent hospitals. It intends to expand its relationships with overseas Contract Research Organisations and sees Ecron Acunova as a good partner.
Ecron Acunova CRO is a leading CRO in India and continental Europe, having subsidiaries in Europe and the US. It intends to expand its operation in UK and sees Newcastle University as a way of deepening its presence in the UK market.
The two organisations have pledged to continue detailed discussions about mutually beneficial working relationships.
As a beginning to this relationship, Ecron Acunova has contracted first clinical research study at Newcastle University.
Patient-derived organoids: Transforming cancer research and personalized medicine